Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPEC.
Ekaterina BaronArmando SardiMary Caitlin KingAndrei NikiforchinFelipe Lopez-RamirezCarol NierodaVadim GushchinPanayotis LedakisPublished in: Annals of surgical oncology (2022)
Systemic chemotherapy is associated with improved OS for high-grade MAC patients with unresectable peritoneal metastases who are deemed surgical candidates but underwent an unsuccessful CRS/HIPEC attempt. Further prospective studies with a larger sample are required to identify patient subgroups who benefit the most from SCT.